Elevance Health, Inc. (ELV)

Elevance Health sells health cover and health services. It served approximately 45.2 million medical members through its affiliated health plans at the end of 2025, and describes itself as one of the largest health insurers in the United States by medical membership. Its position rests on something structural: it is an independent licensee of the Blue Cross and Blue Shield Association, which gives it the Blue brands in a defined list of states.

Compare with another name What $10,000 in Elevance Health became

Latest results

Latest quarterQ3 FY2026ended 30 September 2026 · 10-Q filed 21 October 2026

Revenue

$51.4 billion

+1.4% on the year · +1.9% on the quarter

Q4 FY2024Q3 FY2026

Net income

$1.4 billion

+14.8% on the year · -6.7% on the quarter

Q4 FY2024Q3 FY2026

Diluted EPS

$6.27

+17.9% on the year · -6.6% on the quarter

Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

Read the Q3 FY2026 results →the 10-Q on EDGAR ↗

Last full yearFY2025ended 31 December 2025 · 10-K filed 6 February 2026

Revenue

$199.1 billion

+12.5% on the year

FY2018FY2025

Net income

$5.7 billion

-5.3% on the year

FY2018FY2025

Diluted EPS

$25.21

-1.8% on the year

FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The years before, in words

Elevance Health (ELV) reported revenue of $199.1 billion for fiscal 2025, the year ended 31 December 2025, up 12.5% on the year before. Net income was $5.7 billion and diluted earnings per share $25.21. Revenue was $177.0 billion in fiscal 2024, $171.3 billion in fiscal 2023, $156.6 billion in fiscal 2022 and $138.6 billion in fiscal 2021. Net income in the same years was $6.0 billion, $6.0 billion, $5.9 billion and $6.2 billion. Over the twelve months to 30 September 2026, Elevance Health reported revenue of $201.8 billion and net income of $5.1 billion. Revenue grew 10.3% a year, compounded, over the five years to fiscal 2025. Elevance Health declared $6.87 a share in dividends over the last four quarters and had 216 million shares outstanding at the latest filed count. At the close of 6 November 2026 the market cap of Elevance Health was $92.0 billion, 18.1 times its earnings over the last twelve months.

Read the FY2025 results →the 10-K on EDGAR ↗

Ratios

From the filings

ROE11.5%

ROCE7.2%

Operating margin2.7%

Net margin2.5%

FCF margin3.2%

Interest cover3.8x

Debt to equity0.69x

Cash conversion1.48x

Share count, last 12 months-2.7%

Sales CAGR, 3 years8.3%

Profit CAGR, 3 years-1.3%

EPS, TTM$23.45

At the close of 6 November 2026

Price$425.60

Market cap$92.0 billion

Stock P/E18.1x

Price to book2.1x

EV / EBITDA16.2x

Dividend yield1.6%

Market cap / sales0.46x

52-week high$445.34

52-week low$280.74

Price, 1 year35.4%

Price CAGR, 3 years-2.4%

Price CAGR, 5 years0.2%

29 ready-made ratios, from FCF yield to net debt to EBITDA, wait on the Formulas page, each with what it tells you. Browse and add them →

Worked from the filed figures; hover a name for the formula.

The priced ones use the latest price, the last regular-hours trade on IEX. Debt to equity here stands on long-term debt as Elevance Health, Inc. files it, with lease liabilities counted separately and never inside it. Nothing here is a valuation or a view.

Show

ELVgreeksoup.ai

50-day average 200-day average Volume

Daily prices to 6 November 2026, adjusted for splits; from 28 September 2026 each day's price is the last regular-hours trade on IEX.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Day by day for the last three years; before that one point a week, carrying the week's last close and its average daily volume, so a volume bar means the same thing across the whole series; the bars sit under the price on their own scale, on the right. The moving averages need consecutive days and are drawn from the daily part. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Before the quarters on file begin, P/E, price to book and market cap to sales stand on each annual report from the day it was filed. Drawn in your browser; the range and overlay you pick are remembered here only.

Quarterly results

	Q4 FY2021 *	Q1 FY2022 †	Q2 FY2022 †	Q3 FY2022 †	Q4 FY2022 * †	Q1 FY2023	Q2 FY2023	Q3 FY2023	Q4 FY2023 *	Q1 FY2024	Q2 FY2024	Q3 FY2024 †	Q4 FY2024 *	Q1 FY2025	Q2 FY2025	Q3 FY2025	Q4 FY2025 *	Q1 FY2026	Q2 FY2026	Q3 FY2026
Revenue	36,581	38,095	38,632	39,939	39,929	42,172	43,672	42,849	42,647	42,577	43,886	45,106	45,442	48,891	49,776	50,711	49,747	50,181	50,474	51,429
Cost of revenue	3,070	2,883	3,069	3,437	3,646	3,481	4,327	4,648	4,837	3,825	4,820	5,093	6,012	4,983	5,293	5,380	5,522	5,463	5,492	5,640
Gross profit	33,511	35,212	35,563	36,502	36,283	38,691	39,345	38,201	37,810	38,752	39,066	40,013	39,430	43,908	44,483	45,331	44,225	44,718	44,982	45,789
Gross margin	92%	92%	92%	91%	91%	92%	90%	89%	89%	91%	89%	89%	87%	90%	89%	89%	89%	89%	89%	89%
SG&A	4,222	4,341	4,269	4,514	4,562	4,800	4,818	5,470	4,999	4,886	5,066	5,269	4,804	5,300	4,997	5,272	5,415	6,330	5,547	5,752
Operating income	1,188	2,427	2,346	2,251	1,259	2,831	2,628	1,756	1,284	3,016	2,765	1,408	673	3,170	2,425	1,295	309	2,086	1,763	1,269
Operating margin	3%	6%	6%	6%	3%	7%	6%	4%	3%	7%	6%	3%	1%	6%	5%	3%	1%	4%	3%	2%
Interest expense	200	201	208	213	229	251	261	259	259	265	280	300	340	344	341	351	366	357	364	358
Pre-tax income	1,400	2,306	2,122	2,127	1,045	2,619	2,441	1,654	1,001	2,939	2,986	1,373	606	2,797	2,292	1,406	215	2,304	1,937	1,794
Tax rate	20%	23%	23%	25%	16%	23%	24%	21%	17%	23%	23%	27%	32%	22%	24%	16%	-154%	24%	25%	25%
Net income	1,137	1,789	1,637	1,603	865	1,989	1,853	1,289	856	2,246	2,300	1,016	418	2,183	1,743	1,189	547	1,764	1,463	1,365
Net margin	3%	5%	4%	4%	2%	5%	4%	3%	2%	5%	5%	2%	1%	4%	4%	2%	1%	4%	3%	3%
Diluted EPS	$4.64	$7.32	$6.73	$6.62	$3.95	$8.30	$7.79	$5.45	$3.63	$9.59	$9.85	$4.36	$1.81	$9.61	$7.72	$5.32	$2.47	$8.00	$6.71	$6.27
Operating cash flow	1,672	2,541	2,452	4,924	-1,518	6,469	1,950	2,613	-2,971	1,978	447	2,677	706	1,017	2,054	1,135	84.0	4,332	1,913	1,267
Capital expenditure	340	254	295	305	298	301	350	319	326	279	323	332	322	196	267	360	293	235	287	267
Free cash flow	1,332	2,287	2,157	4,619	-1,816	6,168	1,600	2,294	-3,297	1,699	124	2,345	384	821	1,787	775	-209	4,097	1,626	1,000
Buybacks	522	545	624	579	568	622	646	480	928	566	463	60.0	1,811	880	378	876	471	1,124	234	330
Dividends paid	273	309	309	306	305	351	350	348	346	379	378	386	373	386	385	381	377	376	373	373
Shares outstanding	242m	241m	240m	239m	238m	237m	236m	235m	233m	233m	232m	232m	227m	226m	225m	222m	221m	217m	217m	216m
Filing	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q

Each quarter as filed, linked to its filing.

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Income statement (profit and loss)

	FY2007	FY2008 †	FY2009 †	FY2010 †	FY2011 †	FY2012 †	FY2013	FY2014 †	FY2015 †	FY2016 †	FY2017 †	FY2018	FY2019 †	FY2020	FY2021 †	FY2022 †	FY2023	FY2024	FY2025	TTM
Revenue	61,168	61,251	65,028	58,802	60,711	61,497	71,024	73,874	79,156	84,863	90,039	92,105	104,213	121,867	138,639	156,595	171,340	177,011	199,125	201,831
Cost of revenue	433	468	419	0.0	0.0	137	n/a	n/a	n/a	n/a	0.0	0.0	1,992	8,953	10,895	13,035	17,293	19,750	21,178	22,117
Gross profit	60,735	60,783	64,609	58,802	60,711	n/a	n/a	n/a	n/a	n/a	90,039	92,105	102,221	112,914	127,744	143,560	154,047	157,261	177,947	179,714
Gross margin	99.3%	99.2%	99.4%	100.0%	100.0%	n/a	n/a	n/a	n/a	n/a	100.0%	100.0%	98.1%	92.7%	92.1%	91.7%	89.9%	88.8%	89.4%	89.0%
Selling, general and administrative	8,702	8,497	9,019	8,733	8,436	8,680	9,953	11,748	12,535	12,558	12,650	14,020	13,364	17,450	15,914	17,686	20,087	20,025	20,984	23,044
Operating income	5,258	4,348	4,179	4,078	3,782	3,620	4,001	4,418	4,753	4,802	4,175	5,426	5,999	6,360	7,559	8,283	8,499	7,862	7,199	5,427
Operating margin	8.6%	7.1%	6.4%	6.9%	6.2%	5.9%	5.6%	6.0%	6.0%	5.7%	4.6%	5.9%	5.8%	5.2%	5.5%	5.3%	5.0%	4.4%	3.6%	2.7%
Interest expense	448	470	447	419	430	512	603	601	653	723	739	753	746	784	798	851	1,030	1,185	1,402	1,445
Pre-tax income	5,258	3,122	7,403	4,354	3,958	3,858	3,840	4,368	4,631	4,555	3,964	5,068	5,985	6,238	7,995	7,600	7,715	7,904	6,710	6,250
Income tax	1,912	632	2,657	1,467	1,311	1,207	1,206	1,808	2,071	2,086	121	1,318	1,178	1,666	1,846	1,712	1,724	1,933	1,049	1,147
Effective tax rate	36.4%	20.2%	35.9%	33.7%	33.1%	31.3%	31.4%	41.4%	44.7%	45.8%	3.1%	26.0%	19.7%	26.7%	23.1%	22.5%	22.3%	24.5%	15.6%	18.4%
Net income	3,345	2,491	4,746	2,887	2,647	2,656	2,490	2,570	2,560	2,470	3,843	3,750	4,807	4,572	6,158	5,894	5,987	5,980	5,662	5,139
Net margin	5.5%	4.1%	7.3%	4.9%	4.4%	4.3%	3.5%	3.5%	3.2%	2.9%	4.3%	4.1%	4.6%	3.8%	4.4%	3.8%	3.5%	3.4%	2.8%	2.5%
Diluted EPS	$5.56	$4.76	$9.88	$6.94	$7.25	$8.18	$8.20	$8.99	$9.38	$9.21	$14.35	$14.19	$18.47	$17.98	$24.95	$24.28	$25.22	$25.68	$25.21	$23.45
Filing	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-Q	10-Q	10-K	10-K	10-K

From each year's 10-K, linked; TTM is the last four quarters.

Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. † The year as the company last restated it in a later filing; rest on a figure for the one first filed. EPS is as filed.

Cash flow

	FY2007	FY2008 †	FY2009 †	FY2010 †	FY2011 †	FY2012 †	FY2013	FY2014 †	FY2015 †	FY2016 †	FY2017 †	FY2018	FY2019 †	FY2020	FY2021 †	FY2022 †	FY2023	FY2024	FY2025	TTM
Operating cash flow	4,345	2,535	3,039	1,417	3,374	2,745	3,052	3,369	4,212	3,270	4,185	3,827	6,061	10,688	8,364	8,399	8,061	5,808	4,290	7,596
Capital expenditure	322	346	378	451	520	545	646	715	638	584	791	1,208	1,077	1,021	1,087	1,152	1,296	1,256	1,116	1,082
Free cash flow	4,023	2,190	2,660	965	2,855	2,200	2,406	2,655	3,574	2,686	3,394	2,619	4,984	9,667	7,277	7,247	6,765	4,552	3,174	6,514
Free cash flow margin	6.6%	3.6%	4.1%	1.6%	4.7%	3.6%	3.4%	3.6%	4.5%	3.2%	3.8%	2.8%	4.8%	7.9%	5.2%	4.6%	3.9%	2.6%	1.6%	3.2%
Cash from investing	-769	616	3,003	-1,272	-942	-4,552	-2,234	-975	-1,152	-514	-5,082	-1,259	-2,792	-7,324	-9,638	-4,560	-5,572	-5,167	-1,344	-3,006
Cash from financing	-3,410	-3,736	-3,403	-3,169	-2,019	2,089	-1,718	-1,822	-3,093	-799	427	-2,241	-2,266	-2,567	423	-1,318	-3,349	1,193	-1,738	-2,935
Depreciation and amortisation	411	392	373	345	335	340	353	327	336	296	280	1,132	1,133	1,154	1,302	1,675	1,745	1,393	1,546	1,489
Share-based compensation	177	156	154	136	135	146	146	169	148	165	170	226	294	283	255	264	289	191	276	240
Buybacks	6,151	3,276	2,638	4,360	3,040	2,497	1,620	2,999	1,516	0.0	1,998	1,685	1,701	2,700	1,900	2,316	2,676	2,900	2,605	2,159
Dividends paid	n/a	n/a	n/a	0.0	358	367	448	481	657	684	705	776	818	954	1,104	1,229	1,395	1,508	1,529	1,499
Dividend per share	n/a	n/a	n/a	$0.00	$1.00	$1.15	$1.50	$1.75	$2.50	$2.60	$2.70	$3.00	$3.20	$3.80	$4.52	$5.12	$5.92	n/a	n/a	$6.87
Diluted shares, weighted	n/a	523m	480m	416m	365m	325m	304m	286m	273m	268m	268m	264m	260m	254m	247m	243m	237m	233m	225m	218m
Shares outstanding at period end	n/a	503m	450m	378m	339m	305m	293m	268m	261m	264m	256m	257m	253m	245m	242m	238m	233m	227m	221m	216m
Filing	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-Q	10-Q	10-K	10-K	10-K

Cash paid in the year, from the cash flow statement.

The dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet

	FY2007	FY2008 †	FY2009 †	FY2010 †	FY2011 †	FY2012 †	FY2013	FY2014 †	FY2015 †	FY2016 †	FY2017 †	FY2018	FY2019 †	FY2020	FY2021 †	FY2022 †	FY2023	FY2024	FY2025	TTM
Funded by
Shareholders' equity	22,990	21,432	24,863	23,813	23,288	23,803	24,765	24,251	23,044	25,100	26,503	28,541	31,728	33,199	36,060	36,307	39,306	41,315	43,882	44,681
Non-controlling interest	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	26.0	n/a	0.0	68.0	87.0	99.0	111	144	113
Short-term borrowings	n/a	98.0	0.0	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.0	n/a	n/a	n/a	n/a	150	0.0
Debt	n/a	8,744	8,399	8,954	9,840	14,978	14,492	15,044	15,864	15,727	19,932	19,211	20,085	20,035	23,031	24,114	25,120	31,232	31,896	30,757
Operating lease liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	864	751	685	658	529	n/a
Other liabilities	n/a	18,130	18,863	17,401	19,035	20,175	20,318	22,381	22,809	24,256	24,105	23,793	25,640	33,381	37,437	41,513	43,718	43,573	44,893	52,250
Total liabilities and equity	n/a	48,403	52,125	50,167	52,163	58,955	59,574	61,676	61,718	65,083	70,540	71,571	77,453	86,615	97,460	102,772	108,928	116,889	121,494	127,801
Owned
Fixed assets	n/a	1,054	1,100	1,156	1,418	1,717	1,802	1,944	2,020	1,978	2,175	2,735	3,133	3,483	3,919	4,316	4,359	4,652	4,679	4,613
Goodwill	n/a	13,461	13,265	13,265	13,859	16,890	16,917	17,082	17,562	17,561	19,231	20,504	20,500	21,691	24,228	24,383	25,317	28,277	28,344	28,343
Intangible assets	n/a	8,827	8,259	7,997	7,932	8,666	8,441	7,958	8,158	7,965	8,368	9,007	8,674	9,405	10,615	10,315	10,273	12,094	11,200	10,877
Investments	n/a	13,373	15,927	16,291	16,160	17,344	17,488	17,972	17,478	17,688	17,938	17,179	20,181	23,995	26,899	26,704	30,490	26,236	27,005	26,558
Cash and equivalents	2,768	2,184	4,816	1,789	2,202	2,475	1,582	2,152	2,114	4,075	3,609	3,934	4,937	5,741	4,880	7,387	6,526	8,288	9,491	10,348
Other assets	n/a	9,503	8,758	9,670	10,593	11,863	13,345	14,568	14,386	15,816	19,218	18,212	20,028	22,300	26,919	29,667	31,963	37,342	40,775	47,062
Total assets	n/a	48,403	52,125	50,167	52,163	58,955	59,574	61,676	61,718	65,083	70,540	71,571	77,453	86,615	97,460	102,772	108,928	116,889	121,494	127,801
Filing	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-Q	10-Q	10-K	10-K	10-K

At the fiscal year end; the TTM column is the latest quarter end.

Both totals are the company's own. Other liabilities is the filed total less the rows above it: payables, deferred revenue, taxes, borrowings the rows above do not carry and the rest; other assets is the same on the other side. Investments add the current and non-current lines as filed. Debt is the company's own stated total where it files one, otherwise its long-term debt with the current maturities, never parts added together. A row is left blank in a year where the lines shown overlap and the remainder would fall below nil.

Compounded growth

	10 years	5 years	3 years	TTM
Sales growth, compounded	9.7%	10.3%	8.3%	3.6%
Profit growth, compounded	8.3%	4.4%	-1.3%	-7.1%
Return on equity, average	14.2%	15.2%	14.2%	12.9%

Yearly growth, compounded; TTM is the last four quarters against the four before.

Return on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Questions

What was Elevance Health's revenue in fiscal 2025?

Elevance Health (ELV) reported revenue of $199.1 billion for fiscal 2025, the year ended 31 December 2025, up 12.5% on the year before.

How much did Elevance Health earn in fiscal 2025?

Net income was $5.7 billion for fiscal 2025, and diluted earnings per share $25.21.

What is Elevance Health's P/E ratio?

At the close of 6 November 2026, Elevance Health traded at 18.1 times its earnings over the twelve months to 30 September 2026.

What is Elevance Health's market cap?

The market cap of Elevance Health was $92.0 billion at the close of 6 November 2026.

Does Elevance Health pay a dividend?

Yes. Elevance Health declared $6.87 a share in dividends over the four quarters to 30 September 2026.

Peers: Insurance

Company	Market cap	P/E	ROE	Op. margin	Sales growth TTM	Debt to equity	Div. yield
UnitedHealth Group Inc. UNH	$353.2 billion	22.51	15.3%	5.3%	3.3%	0.71	2.3%
Marsh & McLennan Companies, Inc. MRSH	$97.3 billion	24.49	27.1%	21.4%	7.6%	1.27	1.8%
Elevance Health, Inc. ELV	$92.0 billion	18.15	11.5%	2.7%	3.6%	0.69	1.6%
Travelers Companies, Inc. TRV	$81.0 billion	10.31	28.7%	21.2%	1.1%	0.34	1.2%
Cigna Group CI	$77.4 billion	12.96	13.8%	3.4%	6.8%	0.72	2.1%
Humana Inc. HUM	$52.1 billion	42.17	6.6%	1.5%	22.0%	0.66	0.8%
Centene Corp. CNC	$34.5 billion	23.88	6.6%	0.5%	9.7%	0.70	n/a
Molina Healthcare, Inc. MOH	$10.8 billion	n/a	-1.2%	0.4%	-0.9%	0.91	n/a
Oscar Health, Inc. OSCR	$9.5 billion	12.66	38.5%	5.4%	54.8%	0.19	n/a
Clover Health Investments, Corp. CLOV	$2.6 billion	483.00	3.2%	0.5%	54.5%	0.00	n/a
Trupanion, Inc. TRUP	$1.6 billion	60.31	6.7%	1.8%	11.4%	0.26	n/a
Alignment Healthcare, Inc. ALHC	$1.5 billion	56.38	10.4%	0.9%	35.9%	1.17	n/a

All 112 in Insurance

Company	Market cap	P/E	ROE	Op. margin	Sales growth TTM	Debt to equity	Div. yield
Berkshire Hathaway Inc. BRK.B	$1.23 trillion	14.36	11.5%	15.0%	3.9%	n/a	n/a
UnitedHealth Group Inc. UNH	$353.2 billion	22.51	15.3%	5.3%	3.3%	0.71	2.3%
Chubb Ltd. CB	$139.6 billion	12.77	15.3%	22.3%	5.7%	0.25	1.1%
Progressive Corp. PGR	$132.0 billion	11.48	33.7%	16.0%	7.7%	0.24	6.1%
Marsh & McLennan Companies, Inc. MRSH	$97.3 billion	24.49	27.1%	21.4%	7.6%	1.27	1.8%
Elevance Health, Inc. ELV	$92.0 billion	18.15	11.5%	2.7%	3.6%	0.69	1.6%
Travelers Companies, Inc. TRV	$81.0 billion	10.31	28.7%	21.2%	1.1%	0.34	1.2%
Cigna Group CI	$77.4 billion	12.96	13.8%	3.4%	6.8%	0.72	2.1%
Manulife Financial Corporation MFC *	$72.5 billion	19.66	11.1%	n/a	n/a	0.15	3.3%
Arthur J. Gallagher & Co. AJG	$72.2 billion	43.06	7.1%	13.1%	25.6%	0.54	1.0%
Aon plc AON	$71.0 billion	18.34	38.9%	26.3%	3.8%	2.61	0.9%
Allstate Corp. ALL	$63.4 billion	5.77	35.9%	21.1%	5.1%	0.23	1.7%
Metlife Inc. MET	$62.0 billion	12.80	23.1%	8.2%	14.8%	0.64	2.4%
Aflac Inc. AFL	$61.5 billion	18.24	12.0%	25.9%	-6.2%	0.28	1.9%
Humana Inc. HUM	$52.1 billion	42.17	6.6%	1.5%	22.0%	0.66	0.8%
Prudential Financial Inc. PRU	$40.9 billion	10.86	13.1%	7.8%	6.5%	0.67	4.7%
American International Group, Inc. AIG	$40.3 billion	12.66	8.5%	14.5%	1.2%	0.22	2.4%
Sun Life Financial Inc. SLF *	$39.6 billion	16.24	14.5%	n/a	8.0%	0.33	3.7%
Hartford Insurance Group, Inc. HIG	$35.8 billion	8.11	24.4%	18.2%	6.2%	0.23	1.8%
Arch Capital Group Ltd. ACGL	$34.9 billion	8.78	19.0%	25.9%	-3.9%	0.19	4.7%
Centene Corp. CNC	$34.5 billion	23.88	6.6%	0.5%	9.7%	0.70	n/a
Everest Group, Ltd. EG	$30.6 billion	8.69	13.3%	13.9%	-8.7%	n/a	1.9%
Willis Towers Watson plc WTW	$30.3 billion	20.07	20.1%	22.0%	4.8%	0.84	1.2%
Cincinnati Financial Corp. CINF	$28.5 billion	10.88	16.5%	24.8%	9.9%	0.05	2.0%
W. R. Berkley Corp. WRB	$27.9 billion	15.91	19.4%	n/a	1.5%	n/a	2.5%
Markel Group Inc. MKL	$23.7 billion	13.77	9.7%	15.7%	2.5%	0.24	n/a
Principal Financial Group Inc. PFG	$23.6 billion	12.35	16.7%	14.7%	5.2%	0.37	2.9%
Brown & Brown, Inc. BRO	$23.6 billion	22.82	9.7%	n/a	26.1%	0.62	0.9%
Loews Corp. L	$22.2 billion	15.20	8.1%	10.8%	2.8%	0.46	0.2%
Reinsurance Group of America Inc. RGA	$17.0 billion	10.12	14.7%	8.0%	22.5%	0.46	1.4%
Assurant, Inc. AIZ	$15.1 billion	14.45	17.9%	9.8%	9.4%	n/a	1.1%
Corebridge Financial, Inc. CRBG	$15.0 billion	7.31	32.7%	16.6%	13.3%	0.83	2.9%
Globe Life Inc. GL	$14.5 billion	10.53	17.9%	23.3%	5.6%	0.45	0.8%
Renaissancere Holdings Ltd. RNR	$14.2 billion	9.78	13.8%	30.1%	-20.9%	0.21	0.5%
Equitable Holdings, Inc. EQH	$14.1 billion	10.11	n/a	16.3%	8.6%	n/a	2.2%
CNA Financial Corp. CNA	$12.8 billion	12.47	10.1%	8.5%	2.1%	0.24	8.2%
American Financial Group Inc. AFG	$12.8 billion	12.61	21.6%	15.2%	3.3%	0.39	4.5%
Erie Indemnity Co. ERIE	$12.6 billion	24.78	22.6%	17.9%	2.0%	n/a	2.1%
Unum Group UNM	$11.9 billion	54.43	2.3%	2.4%	-4.2%	0.35	2.5%
Fidelity National Financial, Inc. FNF	$11.7 billion	11.21	14.2%	17.0%	6.4%	0.59	4.7%
Molina Healthcare, Inc. MOH	$10.8 billion	n/a	-1.2%	0.4%	-0.9%	0.91	n/a
Oscar Health, Inc. OSCR	$9.5 billion	12.66	38.5%	5.4%	54.8%	0.19	n/a
Old Republic International Corp. ORI	$9.5 billion	8.92	18.8%	13.8%	12.5%	n/a	9.2%
Voya Financial, Inc. VOYA	$8.9 billion	15.92	16.4%	8.9%	-0.3%	0.55	1.9%
Primerica, Inc. PRI	$8.9 billion	11.48	28.2%	29.4%	8.3%	0.21	1.6%
Jackson Financial Inc. JXN	$8.7 billion	10.73	10.4%	56.7%	34.1%	0.33	2.7%
Kinsale Capital Group, Inc. KNSL	$8.6 billion	16.72	27.4%	33.7%	8.3%	0.12	0.2%
Hanover Insurance Group, Inc. THG	$8.3 billion	11.61	21.8%	15.2%	5.0%	0.25	n/a
Axis Capital Holdings Ltd. AXS	$7.6 billion	8.06	16.1%	17.5%	9.8%	0.21	1.7%
Lincoln National Corp. LNC	$7.6 billion	2.48	35.2%	20.0%	10.3%	0.68	4.5%
First American Financial Corp. FAF	$6.8 billion	9.44	13.6%	11.9%	14.1%	n/a	3.3%
Enact Holdings, Inc. ACT	$6.3 billion	9.67	13.1%	68.5%	2.5%	0.14	1.9%
RLI Corp. RLI	$6.3 billion	15.93	23.3%	25.8%	4.6%	0.18	3.9%
Hagerty, Inc. HGTY	$6.2 billion	n/a	23.4%	4.5%	-0.9%	0.96	n/a
Selective Insurance Group Inc. SIGI	$5.9 billion	11.95	14.8%	11.9%	4.0%	0.26	1.7%
Mgic Investment Corp. MTG	$5.8 billion	8.89	14.3%	73.2%	-2.2%	n/a	2.2%
Essent Group Ltd. ESNT	$5.6 billion	8.67	12.2%	59.2%	9.6%	n/a	2.1%
White Mountains Insurance Group Ltd. WTM	$5.4 billion	5.95	18.1%	30.7%	44.9%	0.17	0.0%
CNO Financial Group, Inc. CNO	$5.1 billion	12.66	18.0%	14.8%	2.3%	0.58	1.2%
Radian Group Inc. RDN	$4.7 billion	8.81	12.0%	38.3%	65.3%	0.13	2.8%
Mercury General Corp. MCY	$4.6 billion	7.12	22.9%	12.9%	5.4%	0.20	1.5%
Accelerant Holdings ARX	$4.3 billion	n/a	-180.6%	-110.8%	n/a	0.17	n/a
Corvel Corp. CRVL	$4.2 billion	34.94	28.2%	n/a	8.3%	n/a	n/a
Palomar Holdings, Inc. PLMR	$4.1 billion	19.51	22.0%	22.8%	58.5%	0.30	n/a
Neptune Insurance Holdings Inc. NP	$3.9 billion	90.02	n/a	41.3%	n/a	n/a	n/a
Hamilton Insurance Group, Ltd. HG	$3.6 billion	7.06	31.2%	28.3%	14.8%	0.05	n/a
Assured Guaranty Ltd. AGO	$3.2 billion	10.40	6.0%	33.8%	-4.2%	0.32	2.0%
Genworth Financial Inc. GNW	$3.2 billion	67.00	0.6%	3.3%	-0.6%	0.17	n/a
Lemonade, Inc. LMND	$3.1 billion	n/a	-30.6%	-12.6%	69.5%	n/a	n/a
F&G Annuities & Life, Inc. FG	$3.1 billion	3.10	23.8%	n/a	-0.4%	0.51	4.3%
Slide Insurance Holdings, Inc. SLDE	$3.0 billion	5.89	44.8%	50.4%	n/a	0.02	n/a
SiriusPoint Ltd. SPNT	$3.0 billion	6.40	22.5%	17.6%	18.1%	0.30	n/a
Baldwin Insurance Group, Inc. BWIN	$3.0 billion	n/a	-9.2%	-6.9%	18.9%	2.67	n/a
NMI Holdings, Inc. NMIH	$2.9 billion	7.66	14.5%	68.1%	6.9%	n/a	n/a
Skyward Specialty Insurance Group, Inc. SKWD	$2.7 billion	14.07	15.0%	13.5%	35.3%	0.33	n/a
Porch Group, Inc. PRCH	$2.6 billion	246.38	127.2%	7.7%	23.4%	53.60	n/a
Clover Health Investments, Corp. CLOV	$2.6 billion	483.00	3.2%	0.5%	54.5%	0.00	n/a
Brighthouse Financial, Inc. BHF	$2.5 billion	4.37	13.6%	14.0%	-9.4%	0.63	n/a
HCI Group, Inc. HCI	$2.3 billion	7.52	29.3%	49.6%	20.1%	0.03	0.9%
Horace Mann Educators Corp. HMN	$2.2 billion	12.41	12.5%	12.5%	4.2%	0.42	2.7%
Goosehead Insurance, Inc. GSHD	$2.0 billion	40.58	n/a	23.3%	17.7%	n/a	n/a
Kemper Corp. KMPR	$2.0 billion	n/a	-22.6%	n/a	-4.5%	0.43	3.8%
Trupanion, Inc. TRUP	$1.6 billion	60.31	6.7%	1.8%	11.4%	0.26	n/a
Alignment Healthcare, Inc. ALHC	$1.5 billion	56.38	10.4%	0.9%	35.9%	1.17	n/a
Safety Insurance Group Inc. SAFT	$1.5 billion	21.82	8.2%	7.0%	4.6%	0.06	3.5%
Twfg, Inc. TWFG	$1.5 billion	47.51	17.4%	17.3%	36.2%	0.05	n/a
Stewart Information Services Corp. STC	$1.4 billion	11.77	7.2%	5.2%	20.5%	0.39	4.5%
Universal Insurance Holdings, Inc. UVE	$1.3 billion	5.83	36.0%	19.0%	5.5%	0.15	1.3%
United Fire Group Inc. UFCS	$1.2 billion	9.10	14.6%	11.5%	11.6%	0.16	1.6%
Ategrity Specialty Insurance Co. Holdings ASIC	$1.2 billion	12.17	15.0%	24.4%	n/a	n/a	0.0%
Bowhead Specialty Holdings Inc. BOW	$1.1 billion	19.15	13.3%	11.7%	23.8%	0.33	n/a
Heritage Insurance Holdings, Inc. HRTG	$983 million	4.67	36.1%	34.1%	2.3%	0.12	n/a
Hippo Holdings Inc. HIPO	$929 million	28.82	6.8%	6.2%	20.6%	n/a	n/a
Employers Holdings, Inc. EIG	$832 million	25.99	3.5%	4.1%	-13.0%	0.16	2.8%
Donegal Group Inc. DGICA	$701 million	10.02	10.5%	8.9%	-3.4%	n/a	4.0%
Root, Inc. ROOT	$659 million	9.13	24.8%	6.7%	7.9%	0.60	n/a
Ethos Technologies Inc. LIFE	$558 million	n/a	-23.0%	-16.1%	n/a	n/a	n/a
Crawford & Co. CRD-A	$554 million	21.94	14.1%	3.9%	-3.6%	0.81	n/a
American Integrity Insurance Group, Inc. AII	$528 million	5.99	23.8%	36.2%	29.3%	0.00	n/a
Greenlight Capital RE, Ltd. GLRE	$522 million	9.45	8.4%	8.8%	3.7%	0.01	n/a
Investors Title Co. ITIC	$483 million	11.98	14.1%	17.7%	8.7%	n/a	4.1%
American Coastal Insurance Corp. ACIC	$475 million	5.74	24.5%	37.7%	-5.3%	0.42	7.5%
Amerisafe Inc. AMSF	$363 million	9.10	17.0%	15.0%	7.7%	n/a	8.3%
NI Holdings, Inc. NODK	$311 million	21.26	6.1%	7.7%	-12.9%	0.01	n/a
Kingstone Companies, Inc. KINS	$296 million	7.12	30.7%	21.2%	24.5%	0.03	0.8%
Mbia Inc. MBI	$235 million	n/a	n/a	-155.2%	18.0%	n/a	n/a
Kingsway Corp. KWY	$230 million	n/a	-79.5%	0.7%	23.6%	5.13	n/a
Octave Specialty Group Inc. OSG	$226 million	n/a	-23.0%	-24.3%	26.8%	0.22	n/a
Citizens, Inc. CIA	$208 million	25.69	4.0%	3.8%	4.1%	n/a	n/a
James River Group Holdings, Inc. JRVR	$180 million	10.14	5.8%	3.8%	-1.8%	n/a	1.0%
Roadzen Inc. RDZN	$100 million	n/a	n/a	-21.6%	30.5%	n/a	n/a
Ryan Specialty Holdings, Inc. RYAN	n/a	n/a	23.4%	15.6%	9.8%	8.23	1.1%

9 companies share its SEC industry code (Hospital & Medical Service Plans); the rest are the names nearest in size in its wider industry, Insurance, one of the Fama-French 48 industries, a published grouping of SEC industry codes.

By market capitalisation; a click on a heading sorts by it, largest first, and a second click turns it round. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close; a name marked * is a foreign company that files once a year, on its latest fiscal year.

The public record on ELV

Dividends	$6.87 a share over the four quarters to 30 September 2026, a 1.61% yield
Filings	21 in twelve months: 12 current reports (8-K), about 5 regulation FD disclosure; 4 results of operations; 2 officer or director change; 1 shareholder vote; 1 other events
Planned insider sales	7 Form 144 notices in twelve months, $7.6 million; latest 5 November 2026
Options tape	put/call 1.01 by open interest at the 6 November 2026 close; the straddle prices a 6.0% move to 20 November 2026
13F holders	1,618 funds reported a position for the quarter to 30 June 2026; largest BlackRock, Inc.
Insider trading	19 sales and 4 purchases on Form 4 in twelve months
Congress	0 House trades disclosed in six months
Short interest	5.1 million shares short, 4.00 days to cover at 15 October 2026
Documents	the 10-K, the 10-Qs, the proxy and 4 earnings press releases, each linked

Filings

Filing	Period	Filed	Where
10-Q	30 September 2026	21 October 2026	EDGAR
10-Q	30 June 2026	15 July 2026	EDGAR
10-Q	31 March 2026	22 April 2026	EDGAR
10-K	31 December 2025	6 February 2026	EDGAR
10-Q	30 September 2025	21 October 2025	EDGAR
10-Q	30 June 2025	17 July 2025	EDGAR
10-Q	31 March 2025	22 April 2025	EDGAR
10-K	31 December 2024	20 February 2025	EDGAR
10-Q	30 September 2024	17 October 2024	EDGAR
10-Q	30 June 2024	17 July 2024	EDGAR

Reading about a stock somewhere else? Our free Chrome extension, GreekSoup Stock Ticker Lookup: Earnings, Insider Trades, 13F Holders, shows the latest quarter against a year ago, insider trades and 13F holders when you hover a $ticker such as $AAPL.

Elevance Health, Inc. (ELV)